epidemiology and market share
TRANSCRIPT
EPIDEMIOLOGY
Epidemiology is the science that studies the patterns, causes, and effects of health and disease conditions in defined populations. It is the cornerstone of public health and evidence-based practice by identifying risk factors for disease and targets for preventive healthcare.
EPIDEMIOLOGY AND MARKET SIZE Epidemiology and Market Size Database
provides an interactive, comprehensive, and analytical view of the pharmaceutical market in key countries.
The database of epidemiology and market size of provides you with accurate forecast data. Relevant and detailed patient segmentations are provided for each indication, enabling you to evaluate the commercial potential of the market.
Epidemiology Forecast to 2023
ALZHEIMER’S DISEASE EPIDEMIOLOGY FORECAST TO 2023 AD is an irreversible, neurodegenerative
brain disease of the elderly, which leads to a progressive decline in memory and cognitive abilities, such as thinking, language, and learning capacity.
Epidemiologists forecast that by 2023, there will be approximately 17.38 million total prevalent cases of AD across the 9MM.
Epidemiologists expect a 34.3% increase in the total prevalent cases of AD in the 9MM over the next 8 years.
ATRIAL FIBRILLATION EPIDEMIOLOGY FORECAST TO 2023 AF is a disorder of the heart’s electrical
system. The symptoms of AF typically include heart palpitations, irregular and fast heartbeat, chest discomfort, shortness of breath, dizziness, and weakness.
Epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM will grow by 21.8% over the next 8 years, from 10,112,797 diagnosed prevalent cases in 2013 to 12,316,458 diagnosed prevalent cases in 2023.
GLAUCOMAEPIDEMIOLOGY FORECAST TO 2023 Glaucoma is a common, asymptomatic group
of eye diseases that causes damage to the eye's optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people.
Epidemiologists forecast that the total prevalent cases of glaucoma in the 7MM will grow by 14.60% over the next 8 years, from 13,748,430 total prevalent cases in 2013 to 15,761,674 total prevalent cases in 2023, with almost 60% of the total prevalent cases occurring in the US and Japan together.
SEPSISEPIDEMIOLOGY FORECAST TO 2023 Sepsis is a life-threatening complication
arising from an infection; it occurs when the body's response to the infection damages its own tissues and organs.
In the 6MM, the diagnosed incident cases of sepsis will grow from 1,060,052 cases in 2013 to 1,129,816 cases in 2023, at an Annual Growth Rate (AGR) of 0.66% over the forecast period.
Mortality cases will increase from 439,015 cases in 2013 to 531,282 cases in 2023, at an AGR of 2.10% from 2013 to 2023 in the 6MM.
PROSTATE CANCEREPIDEMIOLOGY FORECAST TO 2023 Prostate cancer is a malignant tumor that
forms in the tissues of the prostate, a gland in the male reproductive system found below the bladder.
In 2013, there were a total of 813,462 diagnosed incident cases of prostate cancer in the 9MM.
Epidemiologists forecast that the diagnosed incident cases in the 9MM will increase to 1,106,349 cases by 2023 at an Annual Growth Rate (AGR) of 3.60%.